Clinical Trial Update: Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors [NA]

View source ↗

Summary

This clinical trial update reports on the diagnostic performance of urine and plasma 5-HIAA in patients with small intestine neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor
• Small Intestine Neuroendocrine Tumor

Snippet

Sponsor: CHU de Reims | Conditions: Small-intestine Neuroendocrine Tumors (Carcinoid Tumors) | NA | Status: COMPLETED